An invisible gas that already has a bad reputation for lung cancer may also be raising the odds of ovarian cancer, according to new research that is landing close to home for Metro Detroit. A large U.S. cohort study found that postmenopausal women living in high radon areas had about a 31% higher chance of being diagnosed with ovarian cancer, along with a similar increase in deaths from the disease. The analysis followed roughly 127,500 participants in the Women’s Health Initiative for up to 31 years and is described as the first individual-level study to connect residential radon exposure with ovarian outcomes. If future work backs it up, radon could join the list of potentially preventable environmental risks for women.
What the study found
The peer-reviewed paper, published April 10 in JAMA Network Open, linked participants’ baseline home addresses with U.S. Geological Survey radon zone maps. Researchers compared ovarian cancer cases and deaths across low radon areas (below 2 picocuries per liter, or pCi/L), medium (2 to 4 pCi/L) and high (above 4 pCi/L). After adjusting for known risk factors, women living in high radon zones had a hazard ratio of 1.31, with a 95% confidence interval of 1.11 to 1.54, for both ovarian cancer diagnoses and deaths compared with those in low radon zones.
The association was strongest for serous ovarian tumors, which showed a hazard ratio of 1.38 for women in the highest radon areas compared with the lowest. A subgroup analysis also found that women with a family history of breast cancer who lived in high radon zones had the largest increase in estimated risk, with a hazard ratio of 1.63.
What researchers say and biological ideas
The authors stress that the findings come from an observational study, so it cannot prove that radon directly causes ovarian cancer. Still, they say the pattern looks biologically plausible. As the University of North Dakota noted, lead author Mark Williamson called the work the first individual-level evidence that radon’s ionizing radiation may offer a modifiable target for preventing some ovarian cancers. Senior author Gary Schwartz pointed out that only a minority of homes in the United States have ever been checked for radon, which leaves a lot of unknown exposure on the table.
The research team laid out two main ideas for how radon might affect the ovaries. One involves radon progeny attaching to tiny airborne particles that could reach ovarian tissue. The other centers on possible radon-related hormonal changes. Both theories, they say, are testable in the lab, and they are urging follow-up studies before anyone rewrites medical guidelines.
What Detroit-area homeowners should know
Even as researchers sort out the science, the findings are landing in a region where radon is already on the radar. The new paper comes alongside reminders that parts of Metro Detroit sit in moderate and higher radon potential zones. As WXYZ reported, federal maps from the Environmental Protection Agency show many Detroit suburbs falling into moderate to high categories for radon potential. The EPA stresses that these maps are intended as a general guide, not a verdict on any particular house. The only way to know a home’s radon level is to test it.
When testing does reveal problems, the EPA recommends fixing homes that measure 4 pCi/L or higher, and considering repairs if levels fall between 2 and 4 pCi/L. Certified radon mitigation contractors can substantially lower indoor levels using systems that vent the gas away from living spaces and depressurize the area under a home’s foundation.
How to test and next steps
For homeowners, checking for radon is far less intimidating than it sounds. Short-term test kits are widely available at hardware stores and online, and state and local health departments often offer low-cost versions, according to the CDC. If a test shows elevated levels, public health guidance recommends hiring a qualified mitigation professional to install a sub-slab depressurization system or a similar setup. Those systems can cut indoor radon significantly.
Anyone who wants more context on radon’s known health impacts, including its role in lung disease, can turn to the American Cancer Society. The study’s authors also suggest that women, particularly those with a family history of breast or ovarian cancer, speak with their healthcare providers about how radon fits into their overall risk picture.
Limitations and where the science goes next
The researchers are clear about the study’s limits. In this analysis, radon exposure was estimated using broad regional maps rather than actual measurements from each participant’s home. The Women’s Health Initiative cohort also includes only postmenopausal women. Both factors make it harder to use the results to quickly change individual medical care or screening recommendations.
Even so, the combination of plausible biological mechanisms and a risk factor that can be reduced has public health experts pushing for more studies that replicate and refine the findings, along with targeted testing in communities. For now, one practical takeaway remains unchanged: testing a home is still the only direct way to know how much radon is inside and whether mitigation is necessary.
